Loading insider details...
Beta
Latest Form 4 (Oct 6, 2026): Exercise/Conversion of 3,440 SLDB shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Oct 6, 2026 | Solid Biosciences Inc. (SLDB) | Exercise/Conversion | 3,440 | n/a |
| Jul 7, 2026 | Solid Biosciences Inc. (SLDB) | Exercise/Conversion | 3,440 | n/a |
| Jun 25, 2026 | Foghorn Therapeutics Inc. (FHTX) | Grant/Award | 28,000 | $114.2K |
| Jun 11, 2026 | Solid Biosciences Inc. (SLDB) | Grant/Award | 77,500 | n/a |
| May 12, 2026 | Odyssey Therapeutics, Inc. (ODTX) | Grant/Award | 27,393 | n/a |
| Apr 2, 2026 | Solid Biosciences Inc. (SLDB) | Exercise/Conversion | 3,441 | n/a |
| Feb 19, 2026 | Stoke Therapeutics, Inc. (STOK) | Grant/Award | 193,000 | n/a |
| Jan 7, 2026 | Solid Biosciences Inc. (SLDB) | Exercise/Conversion | 4,573 | n/a |
| Oct 14, 2025 | Stoke Therapeutics, Inc. (STOK) | Grant/Award | 570,000 | n/a |
| Oct 7, 2025 | Solid Biosciences Inc. (SLDB) | Exercise/Conversion | 4,573 | n/a |